ETFs & Funds
View as an RSS Feed
ICo Therapeutics Inc: Conference & Catalyst
Do you have any idea why Phase II data (primary) has yet to be unveiled? If 185 patients received treatment, that means the majority of patients (over 170) were finished with 12-month treatments by April of this year (according to updates from ICO in 2013).
Is it not difficult to believe how 8-month data could not have been processed by now?
May 20, 2014. 12:21 AM
Link to Comment